Rizatriptan ODF (NAL Pharma)

N/A

Report date: 2025/03/26 13:54:09

Base Information

Drug NameRizatriptan ODF (NAL Pharma)
Drug Alias NameRizatriptan orally-dissolving filmNAL1606NAL-1606
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1d (5-HT1d) receptor agonistsSerotonin 1b (5-HT1b) receptor agonists
TargetsSerotonin 1d (5-HT1d) receptorSerotonin 1b (5-HT1b) receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesNal Pharma LTD
China Registration ClassN/A

Develop Information

Active CompaniesNal Pharma LTD
Inactive CompaniesN/A
Active IndicationsMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A